# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 214: Amendment of regulation 293 (prohibition of supply to the public for promotional purposes)

Extent: E+W+S+N.I.

For regulation 293(1) substitute—
“(1) The holder of—
(a) in the case of a medicinal product for sale or supply in Great Britain, a UKMA(GB), UKMA(UK), COR(GB), COR(UK), THR(GB) or THR(UK); or
(b) in the case of a medicinal product for sale or supply in Northern Ireland, a UKMA(NI), UKMA(UK), COR(NI), COR(UK), THR(NI), THR(UK), EU marketing authorisation or Article 126a authorisation,
may not sell or supply a medicinal product for a promotional purpose to a person who is not qualified to prescribe medicinal products.”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/214 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-214
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.